News

Animal Health Investment Europe 2020

11 January 2020
Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2020)

Animal Health Investment Europe 2019

21 January 2019
Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2019)

VetBioNet grant

26 November 2018
VetBioNet grant - Malcisbo wins a grant to perform an APP challenge trial in a BLS3 facility.

Animal Health Investment Europe

25 January 2017
Malcisbo has been selected as emerging company to present at the Animal Health Investment Forum in London (Feb 2017)

CTI (new: Innosuisse) Project on APP

21 December 2016
Malcisbo participates in a CTI-funded research project on the development of a vaccine against APP.

Parasite Glycobiology: A Bittersweet Symphony

12 November 2015
Parasite Glycobiology: A Bittersweet Symphony - Publication in PLOS Pathogens

Malcisbo at Glyco-Summer School in Braga, Portugal 23-25 September 2015

23 September 2015
Malcisbo at Glyco-Summer School in Braga, Portugal 23-25 September 2015 - Malcisbo has been invited to give a presentation on "Novel carbohydrate-based vaccines"

Ranked #47 in the Top 100 in Switzerland

16 September 2015
Ranked #47 in the Top100 in Switzerland - Malcisbo was ranked in the Top100 of Swiss Start-up companies.

Mycotoxin protects against nematodes

27 May 2014
Researchers at the ETH Zurich have isolated a protein from a fungus which combats nematodes.

Malcisbo participates in GlycoPar

01 December 2013
Malcisbo is partner in GlycoPar, an EU FP7 funded training network.

Malcisbo AG, Wagistrasse 27a, CH-8952 Schlieren, Phone: +41 44 732 22 00, This email address is being protected from spambots. You need JavaScript enabled to view it.